Renewed global threat by the novel SARS-CoV-2 variants ‘XBB, BF.7, BQ.1, BA.2.75, BA.4.6’: A discussion
Ranjan K. Mohapatra, Ahmed Mahal, L. V. Simhachalam Kutikuppala, Madhumita Pal, Venkataramana Kandi, Ashish K. Sarangi, Ahmad J. Obaidullah, Snehasish Mishra
Abstract
OPINION article Front. Virol., 23 December 2022Sec. Viral Diversification and Evolution Volume 2 - 2022 | https://doi.org/10.3389/fviro.2022.1077155
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Diversification (marketing strategy)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyPolitical scienceBiologyMedicineBusinessInternal medicineMarketingOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesViral gastroenteritis research and epidemiology